Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Jun 16 2022

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jun-16-2022-3

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 16-Jun-2022 titled Glenmark becomes the First Pharmaceutical Company to launch Indacaterol + Mometasone Fixed-Dose Combination Drug for Asthma in India

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases